PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm doses first participant in Synovial Fluid Trial, page-14

  1. 60 Posts.
    lightbulb Created with Sketch. 10
    Very exciting news! The only point of note is where Paul says,
    '"Additionally, the data generated will form part of Paradigm’s submission package to the TGA for the next step of the provisional approval application". This tells me TGA approvals won't be until later in the year. DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.